TECH - Company ID 0000842023
The table below shows BIO-TECHNE Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $162.19M | $151.79M | $180.57M | $172.57M | $199.09M | $146.63M |
| Short-term investments | $1.07M | $1.07M | $23.74M | - | - | - |
| Receivables | $206.88M | $241.39M | $218.47M | $194.55M | $145.38M | $122.53M |
| Inventory | $189.45M | $179.73M | $171.64M | $141.12M | $116.75M | $103.15M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $608.30M |
| $617.42M |
| $621.48M |
| $605.56M |
| $510.61M |
| $520.92M |
| Property, plant & equipment | $245.72M | $251.15M | $226.20M | $223.24M | $207.91M | $176.83M |
| Goodwill | $980.93M | $972.66M | $872.74M | $822.10M | $843.07M | $728.31M |
| Total assets | $2.56B | $2.70B | $2.64B | $2.29B | $2.26B | $2.03B |
| Accounts payable | $25.31M | $37.97M | $25.68M | $33.87M | $29.38M | $23.09M |
| Total current liabilities | $175.85M | $159.38M | $128.51M | $176.02M | $152.28M | $106.67M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $1.07B | $1.33B | $1.31B | $1.12B | $1.09B | $1.06B |
| Total equity | - | $2.07B | $1.97B | $1.70B | $1.56B | $1.38B |